Invex Therapeutics Ltd Stock Dividends
Invex Therapeutics Ltd Stock Dividends Overview
IXC.AX pays dividends yearly. Last paid amount was $0 at Dec 08, 2023. As of today, dividend yield (TTM) is 0%.
Dividend Yield Range
AI Analysis of IXC.AX
| Dividend Analysis | Generate |
Key Stats
| Dividend Yield (TTM) | 0% |
|---|---|
| Frequency | Yearly |
| 1Y Growth | 0% |
| Payout Ratio | 0 |
| Amount Per Share | $0 |
|
Invex Therapeutics Ltd has not yet announced its next dividend date. Last payment date was: Dec 08, 2023.
|
|
IXC Dividend Payout History
To ensure a understanding of IXC's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 08, 2023 | Dec 08, 2023 | Dec 08, 2023 | $0 | 0% |
Dividend Sustainability
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Sustainability score
Growth potential
IXC Dividend Calculator
Dividend Calculator is designed to forecast the potential returns from IXC dividends based on your individual investment size or the number of shares you own. Simply enter your total investment amount to see the cumulative dividend payment you could receive over a specified period.
Read how to invest in IXC stock here.
Comparing IXC to Sector and Country
IXC.AX pays a solid dividend yield of 0%, which is lower than the average of the bottom 25% of dividend payers in the AU market (0.320%). IXC.AX’s dividend yield is lower than the average of the top 25% of dividend payers in the Healthcare sector in the AU market (1.97%), which means that there are more attractive dividend stocks to consider.
